Statement of Changes in Beneficial Ownership (4)
06 March 2021 - 10:54AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
ADVENT INTERNATIONAL CORP/MA |
2. Issuer Name and Ticker or Trading Symbol
Syneos Health, Inc.
[
SYNH
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
|
|
(Last)
(First)
(Middle)
PRUDENTIAL TOWER, 800 BOYLSTON STREET, SUITE 3300 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
3/3/2021 |
|
(Street)
BOSTON, MA 02199-8069
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
| Class A Common Stock | 3/3/2021 | | S(1) | | 4331222 (1) | D | $74.175 | 11087573 | I | See Notes (4)(5) |
| Class A Common Stock | 3/3/2021 | | S(3) | | 322824 (2) | D | $74.175 | 10764749 (3) | I | See Notes (4)(5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code
(Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) | 8. Price of Derivative Security
(Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Explanation of Responses: |
| (1) | See Exhibit 99.1 for text of footnote (1). |
| (2) | See Exhibit 99.1 for text of footnote (2). |
| (3) | See Exhibit 99.1 for text of footnote (3). |
| (4) | See Exhibit 99.1 for text of footnote (4). |
| (5) | See Exhibit 99.1 for text of footnote (5). |
Remarks:
Exhibit 99.1 (Footnotes to Form 4) and Exhibit 99.2 (Signatures and Joint Filer Information) are incorporated herein by reference. This Form 4 is the first of six Form 4s being filed relating to the same event. This Form 4 has been split into six filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10. Each part will be filed by Designated Filer, Advent International Corporation. |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
ADVENT INTERNATIONAL CORP/MA
PRUDENTIAL TOWER, 800 BOYLSTON STREET
SUITE 3300
BOSTON, MA 02199-8069 |
| X |
|
|
Double Eagle Investor Holdings, L.P.
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA 02199-8069 |
| X |
|
|
Double Eagle GP, LLC
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA 02199-8069 |
| X |
|
|
Advent International GPE VIII-C Limited Partnership
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA 02199-8069 |
| X |
|
|
GPE VIII GP S.a.r.l.
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA 02199-8069 |
| X |
|
|
GPE VIII GP Limited Partnership
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA 02199-8069 |
| X |
|
|
Advent International GPE VIII, LLC
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA 02199-8069 |
| X |
|
|
GPE VII GP S.a.r.l.
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA 02199-8069 |
| X |
|
|
GPE VII GP Limited Partnership
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA 02199-8069 |
| X |
|
|
Advent International GPE VII, LLC
C/O ADVENT INTERNATIONAL CORPORATION
800 BOYLSTON STREET, SUITE 3300
BOSTON, MA 02199-8069 |
| X |
|
|
Signatures
|
| See Exhibit 99.2 | | 3/5/2021 |
| **Signature of Reporting Person | Date |
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jul 2023 to Jul 2024
